127 related articles for article (PubMed ID: 7519672)
21. Human CD4+ T cells can discriminate the molecular and structural context of T epitopes of HIV gp120 and HIV p66.
Manca F; Fenoglio D; Valle MT; Li Pira G; Kunkl A; Ferraris A; Saverino D; Lancia F; Mortara L; Lozzi L
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Jul; 9(3):227-37. PubMed ID: 7540488
[TBL] [Abstract][Full Text] [Related]
22. Humoral responses to linear epitopes on the HIV-1 envelope in seropositive volunteers after vaccine therapy with rgp160.
Loomis LD; Deal CD; Kersey KS; Burke DS; Redfield RR; Birx DL
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Sep; 10(1):13-26. PubMed ID: 7544225
[TBL] [Abstract][Full Text] [Related]
23. Detection of cytotoxic T lymphocytes specific for synthetic peptides of gp160 in HIV-seropositive individuals.
Clerici M; Lucey DR; Zajac RA; Boswell RN; Gebel HM; Takahashi H; Berzofsky JA; Shearer GM
J Immunol; 1991 Apr; 146(7):2214-9. PubMed ID: 1826020
[TBL] [Abstract][Full Text] [Related]
24. A survey of synthetic HIV-1 peptides with natural and chimeric sequences for differential reactivity with Zimbabwean, Tanzanian and Swedish HIV-1-positive sera.
Blomberg J; Lawoko A; Pipkorn R; Moyo S; Malmvall BE; Shao J; Dash R; Tswana S
AIDS; 1993 Jun; 7(6):759-67. PubMed ID: 8363754
[TBL] [Abstract][Full Text] [Related]
25. An HLA-directed molecular and bioinformatics approach identifies new HLA-A11 HIV-1 subtype E cytotoxic T lymphocyte epitopes in HIV-1-infected Thais.
Bond KB; Sriwanthana B; Hodge TW; De Groot AS; Mastro TD; Young NL; Promadej N; Altman JD; Limpakarnjanarat K; McNicholl JM
AIDS Res Hum Retroviruses; 2001 May; 17(8):703-17. PubMed ID: 11429111
[TBL] [Abstract][Full Text] [Related]
26. Conversion of an immunogenic human immunodeficiency virus (HIV) envelope synthetic peptide to a tolerogen in chimpanzees by the fusogenic domain of HIV gp41 envelope protein.
Haynes BF; Arthur LO; Frost P; Matthews TJ; Langlois AJ; Palker TJ; Hart MK; Scearce RM; Jones DM; McDanal C
J Exp Med; 1993 Mar; 177(3):717-27. PubMed ID: 7679708
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of a new dot blot assay for confirmation of human immunodeficiency virus type 1 and 2 infections using recombinant p24, gp41, gp120 and gp36 antigens.
Ravanshad M; Sabahi F; Mahboudi F; Kazemnejad A
Saudi Med J; 2006 Jan; 27(1):31-6. PubMed ID: 16432590
[TBL] [Abstract][Full Text] [Related]
28. Distinct patterns of peripheral HIV-1-specific interferon- gamma responses in exposed HIV-1-seronegative individuals.
Kebba A; Kaleebu P; Rowland S; Ingram R; Whitworth J; Imami N; Gotch F
J Infect Dis; 2004 May; 189(9):1705-13. PubMed ID: 15116309
[TBL] [Abstract][Full Text] [Related]
29. Confronting the hypervariability of an immunodominant epitope eliciting virus neutralizing antibodies from the envelope glycoprotein of the human immunodeficiency virus type 1 (HIV-1).
Neurath AR; Strick N
Mol Immunol; 1990 Jun; 27(6):539-49. PubMed ID: 1696353
[TBL] [Abstract][Full Text] [Related]
30. Characterization of human immunodeficiency virus type 1-specific cytotoxic T lymphocyte clones isolated during acute seroconversion: recognition of autologous virus sequences within a conserved immunodominant epitope.
Safrit JT; Andrews CA; Zhu T; Ho DD; Koup RA
J Exp Med; 1994 Feb; 179(2):463-72. PubMed ID: 8294860
[TBL] [Abstract][Full Text] [Related]
31. Antibody responses to HIV-1 envelope and gag epitopes in HIV-1 seroconverters with rapid versus slow disease progression.
Zwart G; van der Hoek L; Valk M; Cornelissen MT; Baan E; Dekker J; Koot M; Kuiken CL; Goudsmit J
Virology; 1994 Jun; 201(2):285-93. PubMed ID: 7514319
[TBL] [Abstract][Full Text] [Related]
32. Cytotoxic T lymphocytes specific for the synthetic VEINCTR peptide, a sequence found within the Fas molecule and env gp120 in the blood of HIV-1 seropositive individuals.
Moukrim Z; Achour A
Cell Mol Biol (Noisy-le-grand); 1995 May; 41(3):439-44. PubMed ID: 7580839
[TBL] [Abstract][Full Text] [Related]
33. Kinetics and specificities of the T helper-cell response to gp120 in the asymptomatic stage of HIV-1 infection.
Geretti AM; Van Baalen CA; Borleffs JC; Van Els CA; Osterhaus AD
Scand J Immunol; 1994 Apr; 39(4):355-62. PubMed ID: 7908456
[TBL] [Abstract][Full Text] [Related]
34. T cell responses to peptides covering the gag p24 region of HIV-1 occur in HIV-1 seronegative individuals.
Vyakarnam A; Matear PM; Cranenburg C; Michie C; Beverley PC; Wahren B; Gill SK; Weller I
Int Immunol; 1991 Oct; 3(10):939-47. PubMed ID: 1721834
[TBL] [Abstract][Full Text] [Related]
35. HIV type 1 envelope glycoprotein 120 carboxy-terminal peptide-induced human T cell lines selectively suppress heterogeneous proliferative T cell responses to soluble antigens.
Wilson SE; Habeshaw JA; Addawe MA; Hounsell EF; Oxford JS
AIDS Res Hum Retroviruses; 1997 Oct; 13(15):1313-24. PubMed ID: 9339848
[TBL] [Abstract][Full Text] [Related]
36. Primary in vitro sensitization of human T-helper lymphocytes by peptides derived from the V3 loop of human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein.
Billaud JN; Yagello M; Gluckman JC
Vaccine; 1994 Jan; 12(1):46-55. PubMed ID: 8303940
[TBL] [Abstract][Full Text] [Related]
37. Cytolytic T lymphocytes (CTLs) from HIV-1 subtype C-infected Indian patients recognize CTL epitopes from a conserved immunodominant region of HIV-1 Gag and Nef.
Thakar MR; Bhonge LS; Lakhashe SK; Shankarkumar U; Sane SS; Kulkarni SS; Mahajan BA; Paranjape RS
J Infect Dis; 2005 Sep; 192(5):749-59. PubMed ID: 16088824
[TBL] [Abstract][Full Text] [Related]
38. Common antibody dependent cell mediated cytotoxicity (ADCC) antibody epitopes of HIV-1 CRF01_AE Env and Gag in early HIV-1 infected individuals.
Sangjan S; Ampol S; Tabprasit S; Horthongkham N; Chuenchitra T; Ekpo P; Kantakamalakul W
Asian Pac J Allergy Immunol; 2019 Mar; 37(1):43-50. PubMed ID: 29602284
[TBL] [Abstract][Full Text] [Related]
39. Cross-reactive T-cell proliferative responses to V3 peptides corresponding to different geographical HIV-1 isolates in HIV-seropositive individuals.
Nehete PN; Johnson PC; Schapiro SJ; Arlinghaus RB; Sastry KJ
J Clin Immunol; 1996 Mar; 16(2):115-24. PubMed ID: 8690775
[TBL] [Abstract][Full Text] [Related]
40. False-positive human immunodeficiency virus type 1 western blot tests in noninfected blood donors.
Sayre KR; Dodd RY; Tegtmeier G; Layug L; Alexander SS; Busch MP
Transfusion; 1996 Jan; 36(1):45-52. PubMed ID: 8607152
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]